These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19255288)

  • 1. Antiinflammatory effects of long-acting beta2-agonists in patients with asthma: a systematic review and metaanalysis.
    Sindi A; Todd DC; Nair P
    Chest; 2009 Jul; 136(1):145-154. PubMed ID: 19255288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
    Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
    Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma.
    Castro-Rodriguez JA; Rodrigo GJ
    Pediatrics; 2012 Sep; 130(3):e650-7. PubMed ID: 22926172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
    Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
    Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews.
    Walters JA; Wood-Baker R; Walters EH
    Respir Med; 2005 Apr; 99(4):384-95. PubMed ID: 15763443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of anti-inflammatory effect from addition of a long-acting beta-2 agonist to inhaled corticosteroid.
    Shimoda T; Obase Y; Kishikawa R; Mukae H; Iwanaga T
    Allergy Asthma Proc; 2016 Sep; 37(5):387-93. PubMed ID: 27657522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis.
    Jaeschke R; O'Byrne PM; Mejza F; Nair P; Lesniak W; Brozek J; Thabane L; Cheng J; Schünemann HJ; Sears MR; Guyatt G
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1009-16. PubMed ID: 18776152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists.
    Tomari S; Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Kawano T; Matsuo N; Kohno S
    Respiration; 2008; 76(4):398-402. PubMed ID: 18689991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta-agonists: anti-inflammatory properties and synergy with corticosteroids in asthma.
    Remington TL; Digiovine B
    Curr Opin Pulm Med; 2005 Jan; 11(1):74-8. PubMed ID: 15591892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting beta2-agonists or leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids for the treatment of persistent asthma.
    Ringdal N
    Drugs; 2003; 63 Suppl 2():21-33. PubMed ID: 14984078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
    Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
    Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
    Bjermer L; Diamant Z
    Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.